The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
Portfolio Pulse from Benzinga Insights
Cardlytics (NASDAQ:CDLX) has been analyzed by five analysts, showing a range of opinions from somewhat bullish to somewhat bearish. The average 12-month price target is $4.9, a significant decline from previous targets. Analysts have adjusted their ratings and price targets, reflecting challenges in Cardlytics' financial performance, including negative revenue growth and below-average profitability metrics.
October 11, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cardlytics has received mixed analyst ratings, with a significant drop in the average 12-month price target to $4.9. Analysts have adjusted their ratings due to financial challenges, including negative revenue growth and low profitability metrics.
The significant drop in the average price target and the mixed analyst ratings indicate a bearish sentiment towards Cardlytics. The company's financial challenges, such as negative revenue growth and low profitability, contribute to this outlook. These factors are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100